Dementia therapeutic agent combining pyrazoloquinoline derivative and donepezil Grant US-11833146-B2 United States of America 05 Dec 2023
LEWY BODY DISEASE THERAPEUTIC AGENT CONTAINING PYRAZOLOQUINOLINE DERIVATIVE Grant EP-3632438-B1 European Patent Office 23 Aug 2023
Dementia therapeutic agent combining pyrazoloquinoline derivative and memantine Grant US-11147803-B2 United States of America 19 Oct 2021
PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for… Application US-10513524-B2 United States of America 24 Dec 2019